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COVID-19The coronavirus disease 2019 (COVID-19) emerged in Wuhan city, China, in late 2019 and has rapidly spread
throughout the world. The major route of transmission of SARS-CoV-2 is in contention, with the airborne route
a likely transmission pathway for carrying the virus within indoor environments. Until now, there has been no
evidence for detection of airborne severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and this
may have implication for the potential spread of the COVID-19. We investigated the air of patient rooms with
confirmed COVID-19 in the largest hospital in Iran, on March 17, 2020. To collect the SARS-CoV-2 particles, ten
air samples were collected into the sterile standard midget impingers containing 20 mL DMEM with
100 μg/mL streptomycin, 100 U/mL penicillin and 1% antifoam reagent for 1 h. Besides, indoor particle number
concentrations, CO2, relative humidity and temperature were recorded throughout the sampling duration.Air Pollution Research (CAPR), Institute for Environmental Research (IER), Tehran University of Medical Sciences, 8th Floor, No.
Virology, School of Public Health, Tehran University of Medical Sciences, Qods Avenue, Tehran, Iran.
nvand), mokhtari@tums.ac.ir (T. MokhtariAzad).
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Airborne
Tehran
IranViral RNA was extracted from samples taken from the impingers and Reverse-Transcription PCR (RT-PCR) was
applied to confirm the positivity of collected samples based on the virus genome sequence. Fortunately, in this
study all air samples which were collected 2 to 5m from the patients' beds with confirmed COVID-19 were neg-
ative. Despite we indicated that all air samples were negative, however, we suggest further in vivo experiments
should be conducted using actual patient cough, sneeze and breath aerosols in order to show the possibility of
generation of the airborne size carrier aerosols and the viability fraction of the embedded virus in those carrier
aerosols.
© 2020 Elsevier B.V. All rights reserved.1. Introduction
A novel human coronavirus, named as severe acute respiratory syn-
drome coronavirus 2 (SARS-CoV-2), first detected in Wuhan, China, in
late 2019 (Holshue et al., 2020; Sohrabi et al., 2020). COVID-19 is
spreading rapidly throughout the world; approximately all developed
and developing countries and nations (Amirhossein Takian and
Kazempour-Ardebili, 2020; Holshue et al., 2020; Sohrabi et al., 2020;
van Doremalen et al., 2020a). In Iran, the first official announcement
of death due to COVID-19 was reported by the Ministry of Health and
Medical Education on February 19, 2020 (Amirhossein Takian and
Kazempour-Ardebili, 2020). On March 31, 2020, Iran with 44,605
COVID-19 cases and 2898 its deaths was the 7th and 6th highest rank-
ing, among 203 countries and territories throughout the world which
have experienced COVID-19 outbreak (https://www.worldometers.
info/coronavirus/#countries). Given the rapid spread of COVID-19 glob-
ally, investigations are under way to better understand the potential of
airborne transmissionmode of the virus aswell as the clinical character-
istics and severity of the disease (Ghinai et al., 2020; Guan et al., 2020;
Holshue et al., 2020; Liu et al., 2020; van Doremalen et al., 2020a). Al-
though previously conducted investigations have mainly discussed on
the person-to-person transmission of SARS-CoV-2, its transmission air-
borne mode is controversial (Ghinai et al., 2020; Holshue et al., 2020;
van Doremalen et al., 2020a;Wilder-Smith et al., 2020). It was reported
that airborne transmission plays an important role in the epidemiology
of the two zoonotic coronaviruses that emerged over last two decades,
SARS-CoV-1 and MERS-CoV (van Doremalen et al., 2020a). To date,
the overall evidence regarding the airborne transmission of SARS-CoV-
2 remains incomplete and inconclusive (Ghinai et al., 2020; Ong et al.,
2020; van Doremalen et al., 2020b). To better manage the risks of
COVID-19, particularly for health-care workers (Cheung et al., 2020), it
is extremely crucial to address the importance of airborne transmission
as one of the most important challenge/question of international
COVID-19 outbreak. Hereunder, we investigated the air samples of pa-
tient rooms with severe and critical symptoms to detect the SARS-
CoV-2.
2. Materials and methods
2.1. Study area
We conducted the present study on March 17, 2020 in hospital
wards with confirmed COVID-19 at Imam Khomeini Hospital Complex
in Tehran, Iran. Tehran, with about 9 million residents and the day
time population of near 13 million people who commute into the city
from other cities, is the capital and most populous city of Iran (Faridi
et al., 2018; Yousefian et al., 2020). OnMarch 31, 2020, Tehran province
with the highest confirmed COVID-19 cases ranked the first place
among all provinces in Iran. In the city there are 8 and 13 referral and
emergency hospitals that admit patients with severe and critical symp-
toms. We investigated the indoor air of the wards of intensive care unit
(ICU)-Thorax, Internal, ICU-General and ICU-Heart surgery to detect
SARS-CoV-2 at ImamKhomeini Hospital complex as the largest hospital
in Iran.2.2. Approach to environmental sampling
As a highly efficient approach to sample the airborne viruses, the
impinger techniquewas used in order to collect the air sample of patient
rooms with confirmed COVID-19 (Dart and Thornburg, 2008; Verreault
et al., 2008). We have developed four specific experimental setups that
consists of a vacuum pump with a flow rate equal to 1.5 L·min−1, the
standard midget impinger (from SKC. Inc), rechargeable battery and
connecting tubes. Prior to each sampling campaign, all experimental
setups were autoclaved (impingers) and disinfected (connecting
tubes) using alcohol solution 70% based on the protocol of Centers for
Disease Control and Prevention (https://www.cdc.gov/coronavirus/
2019-ncov/prepare/cleaning-disinfection.html). We installed our ex-
perimental setups in the above-mentioned wards at the height of
about 1.5 to 1.8 m from the floor and approximately 2 to 5 m away
from the patients' beds with severe and critical symptoms (Fig. 1).
Some of the patients coughed during the samples collection. The indoor
air of each of wards (ten air samples) was pumped into the sterile
impinger containing 20 mL of DMEM (Dulbecco's Modified Eagle's Me-
dium) with 100 μg/mL streptomycin, 100 U/mL penicillin and 1% anti-
foam reagent (isoamyl alcohol) for 1 h and the collected samples
immediately transferred to a clinical virology laboratory on ice for de-
tection of the novel coronavirus. A real-time instrument at a flow rate
of 1.2 L·min−1 (GRIMMAerosol Spectrometer,model 11E, GrimmAero-
sol Technik GmbH, Ainring, Germany) was used to monitor the indoor
particle number concentrations (PNC) in thirty-two various size frac-
tions between 0.25 and 32 μm in time intervals of six-second. Addition-
ally, we recorded indoor CO2 concentration, relative humidity and
temperature using AQ110 and HD 110 KIMO (Sauermann Group),
respectively.2.3. SARS-CoV-2 detection
All samples after sampling were transferred to the Virology Lab at
National Influenza Centre (NIC) under cool condition. The samples
then were ultra-centrifuged at 110,000 ×g for 1.5 h at 4 °C, followed
by pellet suspending in the sampling medium. To detect the presence
of SARS-CoV-2 in the air samples, specific primer and probe real-time
reverse transcriptase–polymerase chain reaction (RT-PCR) targeting
RNA-dependent RNA polymerase (RdRp) and Envelop (E) genes was
used to determine viral genomes. Viral RNAwas extracted from sample
material and collected in elution buffer, using a Vazyme Viral RNA/DNA
Mini Kit (Vazyme, China) prior to RT-PCR. PCR amplification were per-
formed using The SuperScript™ III One-Step RT-PCR System with
Platinum™ Taq DNA Polymerase (Invitrogen, USA). Each reaction
contained 12.5 μL Invitrogen 2X Master Mix, 0.5 μl of SARS-CoV-2 spe-
cific primer and probe sets suggested by WHO (ModularDx Kit,
Wuhan Cov RdRP and E gens (Life Science. Berlin, Germany)), 2 L of nu-
clease freewater. Finally, 5 L of RNA samplewere prepared for real-time
PCR (PCR). Prepared reactions were run with initial conditions of 50 °C
for 30 min, 95 °C for 2 min, followed by 45 cycles of 95 °C for 10 s, and
60 °C for 30 s (Applied Biosystems, USA) The ct (cycle threshold) values
higher than 38 were considered as the negative results.
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Table 1 reveals the specifications of all collected samples of SARS-
CoV-2 in the air of hospitalwards, and Table 2 provides additional infor-
mation on environmental status of patient rooms with confirmed
COVID-19. As shown in Table 1, there were forty-four patients con-
firmed with COVID-19 that were receiving oxygen mask (n = 22) and
intubation (n = 22) treatments. Given the Table 1, all air samples
which were taken 2 to 5 m from the patients' beds were negative. Our
results concur with one of the more recent World Health Organization
report on March 27, 2020 (https://www.who.int/news-room/
commentaries/detail/modes-of-transmission-of-virus-causing-covid-
19-implications-for-ipc-precaution-recommendations) and a recent
published article in the Journal of the American Medical Association
(Ong et al., 2020)which indicated SARS-CoV-2 could not be transmitted
by an airborne route, suggesting that airborne transmission is not driv-
ing the pandemic. However, in a recent preprint article by Joshua L.
Santarpia et al. (2020) at University of Nebraska Medical Center, the
viral RNAwas found in air of eleven isolation rooms and in the hallway
spaces. An average of 2.86 copies/L of air in room air samples was re-
ported, suggesting the transportation of aerosols, potentially even in
the absence of cough or aerosol generating procedures. Since the air
sampleswere collected in the negativepressure equipped rooms,we as-
sume air turbulence, causing by recirculating air in those isolation
rooms could remarkably suspend the large droplets for a long period
of time, and finally affect the results. Nevertheless, there are some
other limitations in that study, e.g. the distance of air samplers from
the patient beds was unclear which could limit interpretation for the
importance of airborne transmission. It was also mentioned that the
air samples in the hallways were taken during sampling activities and
samplerswere placed on thefloor adjacent to rooms. The height of sam-
pling is critically important once it comes to investigate the airborne
aerosols. As copies/μL in recovered buffer from the personal air samplers
was approximately in the range of that recovered for the floor under
beds and from personal items, we presume personnel who wore the
samplers likely had close contact with the patients during sampling ac-
tivities (Santarpia et al., 2020). Neeltje and colleagues (2020) in their re-
cent publication using laboratory nebulized SARS-CoV-2 showed that
aerosol transmission of SARS-CoV-2 is plausible, as they found viable
virus in aerosols hours post-nebulization by a Collison nebulizer (van
Doremalen et al., 2020a; vanDoremalen et al., 2020b). The size distribu-
tion of generated aerosols by a Collison nebulizer depends on the type
and viscosity of nebulized fluid. Furthermore, multiples size distribu-
tions were reported for Collison nebulizer. For example, it was reported
that Collison nebulizer produces high concentrations of aerosols which
are relativelymonodispersewith amassmedian aerodynamic diameter
between 1 and 2 μm (Swearengen, 2012). It was reported that COVID-
19 patients are afflicted with the dry and short cough (Ghinai et al.,
2020). Furthermore, the different cough mechanism could produce
large carrier droplets compared to collision nebulizer that may not be
within the airborne size range. It was accepted that one of themain lim-
itations of laboratory carrier aerosols produced by nebulizers is that fail
to adequately represent human aerosols in terms of the physical (size)
and chemical characteristics of respiratory droplets (Vejerano and
Marr, 2018). These properties could markedly change the final fate of
a virus in a respiratory carrier droplet. Moreover, carrier aerosols from
a patient's respiratory system could be spread by coughing, sneezing,
speaking and normal breathing, but the profile and possibility of each
mode of generation to produce airborne SARS-CoV-2 is unknown. A
possible limitation of our study could be that the volume of air collected
for each sample (90 L) influenced the ability to detect a PCR peak. As we
had limited access to the wards, the number of collected samples mightFig. 1. The location of samples (green) and COVID-19 patients' beds (red).
Table 2
Additional information on environmental status of patient rooms with confirmed COVID-19.
# of samples # of windows (status) Area of patient rooms (m2) VSa Tb (°C) RHc (%) CO2 (ppm) PNCd (min-max)
1 4 (close) 335 Mechanical/Natural 23.1 30.5 404 74,388 (56850–88,150)
2 1 (close) 20 Natural 23.5 32.3 438 75,555 (58200–140,750)
3 6 (close) 255 Mechanical/Natural 24.3 26.4 361 155,598 (91700–250,560)
4 167,381 (125800–279,680)
5 5 (close) 215 Mechanical/Natural 28.4 27.0 362 152,135 (95100–256,770)
6 110,026 (93650–183,750)
7 4 (close) 180 Mechanical/Natural 24.0 36.5 361 90,524 (74200–115,350)
8 102,853 (90900–122,550)
9 2 (open) 96 Mechanical/Natural 24.0 28.0 403 107,884 (95700–126,600)




d Particle number concentrations (# of particles/L).
Table 1
SARS-CoV-2 in the air samples of hospital wards.
# of samples Hospital wards # of COVID-19 patients (status) # of staffs SARS-CoV-2 in air sample
1 ICU-Thorax 9 (Oxygen mask: 5, Intubated: 4) 15 Negative
2 Internal 3 (Oxygen mask: 3, Intubated: 0) 2 Negative
3 ICU-General-Part 1 9 (Oxygen mask: 4, Intubated: 5) 12 Negative
4 Negative
5 ICU-General-Part 2 9 (Oxygen mask: 5, Intubated: 4) 12 Negative
6 Negative
7 ICU-Heart surgery - Part 1 8 (Oxygen mask: 3, Intubated: 5) 7 Negative
8 Negative
9 ICU-Heart surgery - Part 2 4 (Oxygen mask: 2, Intubated: 2) 3 Negative
10 ICU heart surgery 2 (Oxygen mask: 0, Intubated: 2) 2 Negative
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patients. For the above discussed reasons, we suggest that in future
in vivo experiments should be conducted using actual human cough,
sneeze and breath aerosols in order to measure; first the possibility of
generation of airborne carrier aerosols by eachmode of aerosol produc-
tion and second the number of viable and total viruses of those aerosols.
Procedures such as intubation could provide the greatest chance of cre-
ating SARS-CoV-2 aerosols. As such health care workers have close con-
tact to the patients, it is imperative that health care workers are
protected by stringent levels of personal protective equipment.
4. Conclusion
The rapid expansion of the COVID-19 is indicative of more efficient
person-to-person transmission and likely its pathway airborne. Conse-
quently, we investigated ten air samples of patient rooms with con-
firmed COVID-19 in the largest clinical hospital in Iran to address the
international challenge regarding the airborne pathway of the SARS-
CoV-2 particles. All air samples were negative. As we collected these
samples 2 to 5 m from the patients' beds, we suggest that all health-
care workers at the clinical hospital who have close contact to the pa-
tients must adhere to national or international evidence based
precautions.
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